DiagnoCure Releases Annual Report
Year-end losses are in line with management expectations and reflect diagnostics development activities undertaken in its commitment to produce high-value test for the detection, management of cancer.
Read MoreMonth: January 2011
AMT Funded For Porphyria Gene Therapy Development
Amsteradam Molecular Therapeutics will receive a third of a 3.3-million pound European Union consortium grant for the development of a gene therapy product for Acute Intermittent Porphyria.
Read MoreBiocare, Jackson Foundation Strike Exclusive Distribution Agreement
Biocare Medical and the Henry M Jackson Foundation for the Advancement of Military Medicine announce exclusive distribution agreement for a highly specific monoclonal antibody.
Read MorePhase 2 Data Show Telatinib’s Potent Antiangiogenic Activity
The results focus on the reported ability to continuously dose telatinib in patients with stomach cancer combined with full-dose, standard-of-care chemotherapy.
Read MoreEvotec, Takeda To Collaborate For Multi-Target Hit Identification
The two companies are partnering to identify molecule modulators against targets involved in various central nervous system and metabolic diseases.
Read More